FAM72B and triple-negative breast carcinoma: Additionally, subsets of triple-negative breast cancer (TNBC) cells expressing FAM72B have been preliminarily identified as being resistant to paclitaxel, suggesting that FAM72B may play a crucial role in tumor resistance mechanisms [32,33].